
Clotrimazole (2% w/v) + Beclometasone (0.025% w/v)
Active composition
+1 more active ingredient
Clotrimazole disrupts the integrity of the fungal cell membrane, leading to leakage of cellular components and death of the fungus.
Beclometasone inhibits the release of pro-inflammatory cytokines, reducing inflammation and immune response.
Medical applications
Fucross-B Solution is a topical medication formulated with Beclometasone (0.025% w/v) and Clotrimazole (2% w/v), designed to effectively treat a variety of inflammatory and fungal skin conditions. Beclometasone, a potent corticosteroid, works by reducing inflammation, redness, and itching, providing rapid symptomatic relief. Clotrimazole, an antifungal agent, targets and eradicates fungal infections by inhibiting the growth of dermatophytes, yeasts, and molds, thereby preventing the spread and recurrence of infection. This combination makes Fucross-B Solution particularly useful in managing mixed infections where inflammation and fungal elements coexist, such as in tinea infections with secondary inflammation or candidiasis with associated dermatitis. The solution form ensures easy application and quick absorption, enhancing patient compliance and therapeutic outcomes. Fucross-B Solution should be applied as directed by a healthcare professional, typically to the affected area twice daily, avoiding contact with eyes and mucous membranes. Prolonged use or use over large areas should be avoided to minimize potential side effects associated with corticosteroids, such as skin thinning or systemic absorption. Overall, Fucross-B Solution offers an effective dual-action treatment for fungal infections complicated by inflammatory symptoms, promoting faster healing and relief.
How to use Fucross-B Solution Use this medicine in the dose and duration as advised by your doctor. Check the label for directions before use.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
No interaction found/established
High Risk
Fucross-B Solution may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Regular Checkup
Fucross-B Solution should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Fucross-B Solution

Beclometasone (0.025% w/v) + Clotrimazole (2% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Clotrimazole disrupts the integrity of the fungal cell membrane, leading to leakage of cellular components and death of the fungus.
Beclometasone inhibits the release of pro-inflammatory cytokines, reducing inflammation and immune response.
Medical applications
Fucross-B Solution is a topical medication formulated with Beclometasone (0.025% w/v) and Clotrimazole (2% w/v), designed to effectively treat a variety of inflammatory and fungal skin conditions. Beclometasone, a potent corticosteroid, works by reducing inflammation, redness, and itching, providing rapid symptomatic relief. Clotrimazole, an antifungal agent, targets and eradicates fungal infections by inhibiting the growth of dermatophytes, yeasts, and molds, thereby preventing the spread and recurrence of infection. This combination makes Fucross-B Solution particularly useful in managing mixed infections where inflammation and fungal elements coexist, such as in tinea infections with secondary inflammation or candidiasis with associated dermatitis. The solution form ensures easy application and quick absorption, enhancing patient compliance and therapeutic outcomes. Fucross-B Solution should be applied as directed by a healthcare professional, typically to the affected area twice daily, avoiding contact with eyes and mucous membranes. Prolonged use or use over large areas should be avoided to minimize potential side effects associated with corticosteroids, such as skin thinning or systemic absorption. Overall, Fucross-B Solution offers an effective dual-action treatment for fungal infections complicated by inflammatory symptoms, promoting faster healing and relief.
How to use Fucross-B Solution Use this medicine in the dose and duration as advised by your doctor. Check the label for directions before use.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
No interaction found/established
High Risk
Fucross-B Solution may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Regular Checkup
Fucross-B Solution should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Fucross-B Solution















